~ Results from two Phase 3 studies, which evaluated upacicalcet in the treatment of patients with secondary hyperparathyroidism (SHPT) with end-stage kidney disease receiving hemodialysis, will be presented ~ ~ SHPT is a common complication of chronic kidney disease (CKD), affecting nearly all patients with kidney failure receiving maintenance dialysis ~ Raleigh, NC, October 2, 2026 – Pathalys …